Jean-Christophe Montigny
Director of Finance/CFO at MEDIAN TECHNOLOGIES
Network origin in Jean-Christophe Montigny first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 14 | |
| Public Company | Pharmaceuticals: Other | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Christophe Montigny via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| GUERBET | Medical Specialties | Chairman Corporate Officer/Principal | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Biophytis, Inc.
 Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Part of Biophytis SA, Biophytis, Inc. operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes. The company is based in Newark, DE. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| European Organisation for Research & Treatment of Cancer | Corporate Officer/Principal Corporate Officer/Principal | ||
Median Technologies, Inc.
 Median Technologies, Inc. Medical/Nursing ServicesHealth Services Part of MEDIAN Technologies SA, Median Technologies, Inc. provides medical imaging services. The company is based in Burlington, MA. The CEO of the company is Fredrik Bjjorn Brag. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
| New York University | College/University | Undergraduate Degree | |
| NCI Experimental Therapeutics Program | Corporate Officer/Principal | ||
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal | |
The Cancer Prevention & Research Institute of Texas
 The Cancer Prevention & Research Institute of Texas BiotechnologyHealth Technology Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX. | Biotechnology | Corporate Officer/Principal | |
Institut Gustave Roussy EURL
 Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Avon Foundation For Women
 Avon Foundation For Women Investment Trusts/Mutual FundsMiscellaneous Avon Foundation For Women provides granting services. The non-profit company is based in New York, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Chairman | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Sarcoma Alliance for Research through Collaboration | Director/Board Member | ||
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Health Center, Inc. | Chief Executive Officer | ||
Macrotarg Ltd.
 Macrotarg Ltd. BiotechnologyHealth Technology Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK. | Biotechnology | Director/Board Member | |
Adaptate Biotherapeutics Ltd.
 Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Telectronics Pacing Systems, Inc.
 Telectronics Pacing Systems, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Telectronics Pacing Systems, Inc. is a company that manufactures pacemakers. The company is based in Philadelphia, PA. | Medical Specialties | Corporate Officer/Principal | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Varioptic SA
 Varioptic SA Electronic ComponentsElectronic Technology Varioptic SA manufactures autofocus lens for digital imaging applications. The firm offers liquid lenses for development of electrowetting technology to create variable focus lenses with no moving parts. The company was founded by Bruno Berge in 2002 and is headquartered in Lyon, France. | Electronic Components | Director of Finance/CFO | |
| Institut de Haute Finance | College/University | Graduate Degree | |
| Em Strasbourg Business School | College/University | Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree | |
| Median Technologies Hong-Kong Ltd. | Director/Board Member | ||
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member | |
| Median Medical Technology Shanghai Co. Ltd. | Director/Board Member | ||
| DANONE | Food: Meat/Fish/Dairy | Public Communications Contact | |
| CASINO, GUICHARD-PERRACHON SA | Food Retail | Public Communications Contact | |
| FNAC DARTY | Electronics/Appliance Stores | Investor Relations Contact | |
Femmes Business Angels
 Femmes Business Angels Investment ManagersFinance Femmes Business Angels operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Béatrice Jauffrineau in 2003 and is headquartered in Paris, France. | Investment Managers | Director/Board Member | |
| CLARIANE SE | Medical/Nursing Services | Investor Relations Contact |
Statistics
International
| United States | 25 |
| France | 14 |
| United Kingdom | 7 |
| Belgium | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 9 |
| Health Services | 5 |
| Commercial Services | 4 |
| Retail Trade | 3 |
Operational
| Director/Board Member | 107 |
| Corporate Officer/Principal | 48 |
| Chairman | 35 |
| Independent Dir/Board Member | 30 |
| Chief Executive Officer | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Kapil Dhingra | 39 |
| Oern Stuge | 38 |
| Eric Rowinsky | 36 |
| Timothy Haines | 36 |
| Jean Franchi | 17 |
| Oran Muduroglu | 13 |
| Marie-Claire Janailhac-Fritsch | 10 |
| Daniel Schneiderman | 8 |
| Nadine Coulm | 7 |
| Fredrik Brag | 6 |
| Bernard Reymann | 6 |
| Nozha Boujemaa | 6 |
| Dimitri Batsis | 5 |
| Samuel Agus | 5 |
| Yan Liu | 5 |
- Stock Market
- Insiders
- Jean-Christophe Montigny
- Company connections
